#DiabetesDrug

A breakthrough study from UCLA is edging closer to turning coma recovery from a distant possibility into a measurable goal. Neuroscientist Dr. Daniel Toker is guiding a multidisciplinary effort that combines artificial intelligence, brain-model research, and a common diabetes medication to explore ways to revive consciousness in patients with severe brain injuries. The work has drawn attention for its potential to transform care for people who are present in body but absent in mind.

Imagine the heartbreak of watching a loved one slip into a coma—a state where the body survives but the person seems lost in a world out of reach. For many Thai families, the agony of disorders of consciousness is all too real, with loved ones trapped in hospital beds, unable to move, speak, or respond. Now, new research led by neuroscientist Dr. Daniel Toker at UCLA is pushing the boundaries of medical science, offering a glimmer of hope that waking up from a coma might one day move from miracle to medical possibility. His work, recently profiled in Big Think, explores how cutting-edge artificial intelligence (AI), brain models, and an unexpected diabetes medication could hold the key to unlocking consciousness for those “locked inside” by severe brain injuries (source: Big Think).